Rtw Investments, LP C4 Therapeutics, Inc. Transaction History

Rtw Investments, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$8.03 - $12.77 $2.21 Million - $3.52 Million	-275,353 Reduced 8.9%	2,819,472 $24.7 Million
Q2 2022 Aug 15, 2022	SELL	$5.06 - $26.46 $7.27 Million - $38 Million	-1,437,157 Reduced 31.71%	3,094,825 $23.3 Million
Q1 2022 May 16, 2022	BUY	$19.99 - $33.23 $40.7 Million - $67.7 Million	2,037,017 Added 81.65%	4,531,982 $110 Million
Q3 2021 Nov 15, 2021	BUY	$35.91 - $50.5 $12.4 Million - $17.5 Million	345,737 Added 16.09%	2,494,965 $111 Million
Q4 2020 Feb 16, 2021	BUY	$22.8 - $37.05 $49 Million - $79.6 Million	2,149,228 New	2,149,228 $68.7 Million

130

63.5M

670K

54.8K

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $208M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Rtw Investments, LP with notifications on news.